Female reproductive factors and the risk of Parkinson’s disease: a nationwide cohort study

被引:0
作者
Jung Eun Yoo
Dong Wook Shin
Wooyoung Jang
Kyungdo Han
Dahye Kim
Hye-Sung Won
Hye Soon Park
机构
[1] Seoul National University Hospital,Department of Family Medicine, Healthcare System Gangnam Center
[2] Sungkyunkwan University School of Medicine,Department of Family Medicine, Supportive Care Center, Samsung Medical Center
[3] Sungkyunkwan University,Department of Digital Health, Samsung Advanced Institute for Health Science and Technology (SAIHST)
[4] GangNeung Asan Hospital,Department of Neurology
[5] University of Ulsan College of Medicine,Department of Statistics and Actuarial Science
[6] Soongsil University,Department of Medical Statistics
[7] The Catholic University of Korea,Department of Obstetrics and Gynecology
[8] Asan Medical Center,Department of Family Medicine
[9] University of Ulsan College of Medicine,undefined
[10] Asan Medical Center,undefined
[11] University of Ulsan College of Medicine,undefined
来源
European Journal of Epidemiology | 2020年 / 35卷
关键词
Parkinson’s disease; Menarche; Menopause; Duration of fertility; Hormone replacement therapy;
D O I
暂无
中图分类号
学科分类号
摘要
There are conflicting finds in the literature regarding the association of female estrogen status and the incidence of Parkinson’s disease (PD). We aimed to investigate whether female reproductive factors are associated with PD. Using the Korean National Health Insurance System database, 4,729,546 postmenopausal women without PD were identified. The new incidence of PD was defined as subjects with an ICD-10 code for PD (G20) and with a rare intractable disease registration code for PD (V124). The Cox proportional hazard models were used to evaluate the associations of various reproductive factors with incidence of PD. During the median follow-up of 5.84 years, 20,816 individuals were diagnosed with PD. An increased risk of PD was observed in subjects with a later age at menarche (≥ 17 years) compared with reference subjects (13 years ≤ age at menarche ≤ 14 years) (adjusted hazard ratio, aHR 1.10, 95% confidence interval, CI 1.05–1.16). As age at menopause increased, risk of PD decreased (P for trend 0.019). Consistently, decreased risk of PD was observed (aHR 0.91, 95% CI 0.85–0.96) in subjects with longer duration of fertility (≥ 40 years of age) compared with shorter duration of fertility (< 30 years of age). Hormone replacement therapy and oral contraceptives independently increased the risk of PD by 17% and 7%, respectively. Female reproductive factors are independent risk factors for PD, with higher risk associated with shorter lifetime exposure to endogenous estrogen.
引用
收藏
页码:871 / 878
页数:7
相关论文
共 116 条
[1]  
de Lau LM(2006)Epidemiology of Parkinson’s disease Lancet Neurol 5 525-535
[2]  
Breteler MM(2004)Are men at greater risk for Parkinson’s disease than women? J Neurol Neurosurg Psychiatry 75 637-639
[3]  
Wooten GF(2000)Parkinson’s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA working group. Italian longitudinal study on aging Neurology 55 1358-1363
[4]  
Currie LJ(2002)Risk tables for parkinsonism and Parkinson’s disease J Clin Epidemiol 55 25-31
[5]  
Bovbjerg VE(2007)Gender differences in Parkinson’s disease J Neurol Neurosurg Psychiatry 78 819-824
[6]  
Lee JK(2007)Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson’s disease Clin Exp Pharmacol Physiol 34 555-565
[7]  
Patrie J(2007)Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications Steroids 72 381-405
[8]  
Baldereschi M(1984)Interaction between estradiol, prolactin, and striatal dopaminergic mechanisms Adv Neurol 40 489-122
[9]  
Di Carlo A(1989)Estrogens and the pathophysiology of Parkinson’s disease Int J Neurosci 45 119-837
[10]  
Rocca WA(2001)Hysterectomy, menopause, and estrogen use preceding Parkinson’s disease: an exploratory case-control study Mov Disord Off J Mov Disord Soc 16 830-209